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Abstract: A convergent total synthesis of Promysalin, a metabolite of Pseudomonas putida 
RW10S1 with antibiotic activity, is described. The synthetic approach is based around a 
salicyldehydroproline core and a dihydroxymyristamide fragment. Crucial steps include a 
MacMillan asymmetric α-hydroxylation applied for the construction of the myristamide 
framework, and a lactam reduction by Superhydride ® to obtain the dehydroproline fragment. 
Because of the modular nature of the synthesis, ready access to analogues for biological 
evaluation is available. 
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1. Introduction 
To survive in a world with limited resources microorganisms have developed elaborate 
mechanisms such as the formation of biofilms and the production of antimicrobial toxins. A 
plethora of new antimicrobial agents have been discovered via the elucidation of the chemical 
compounds used in this bacterial warfare. Indeed, natural products directly from bacterial sources 
account for the majority of currently employed antibiotics.1 Despite having complex structure, 
these compounds are sources of chemical diversity and leads arising from them are often more 
bio-friendly, due to their co-evolution with the target sites in biological systems. 
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In 2011, Li et al.2 isolated a novel metabolite, promysalin (1, Figure 1) produced by a rice-
associated Pseudomonas strain (Pseudomonas putida, RW10S1). 
 
Promysalin displayed a remarkable antagonistic spectrum, selectively inhibiting the growth of 
other Pseudomonas, including P. aeruginosa, at low micromolar concentrations. The compound 
was also shown to promote swarming of the producing organism and surface colonization. The 
most recent studies3 have demonstrated that promysalin disperses established biofilms and 
inhibits pyoverdine production, two pathogenic phenotypes, which may hint at the role the 
metabolite plays in the rhizosphere. These results increased the interest for the compound. 
Li. et al.2 elucidated the structure of promysalin by spectroscopic methods. The compound is 
composed of salicylic acid and 2,8-dihydroxymyristamide connected by a 2-pyrroline-5-carboxy 
moiety. However, no relative or absolute stereochemical assignments at C2, C8 and C16 were 
made in the original paper. 
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Fig. 1. Structure of promysalin (1). 
 
 
2. Result and Discussion 
Due to its intriguing structure and unique bioactivity, we planned to develop a stereoselective 
synthesis of 1, which may, in principle, have a value in the preparation of promysalin itself as 
well as various analogues.  
The molecule, which can be retrosynthetically disconnected at the ester bond, appears well suited 
to a convergent synthetic approach based around a salicyldehydroproline core (A) and a 
dihydroxymyristamide fragment (B) (Scheme 1).  
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Scheme 1. Retrosynthetic analysis of promysalin. PG = Protecting Group. 
 
We envisaged that the most straightforward approach for preparation of the dehydroproline 
moiety of fragment (A) could be a lactam reduction by Superhydride ® (lithium 
triethylborohydride solution), followed by in situ dehydration of the resulting lactamol with 
TFAA and DIPEA, according to Yu’s procedure.4 
As the absolute configuration at the three stereogenic centers had not been established in the 
original paper, we initially focused on the synthesis of a diastereoisomer arbitrarily chosen with 
the (S)-configuration at C16, by assuming the natural (S)-configuration of the proline core in the 
biosynthetic pathway.1 Thus, (S)-pyroglutamic acid ethyl ester 2 was used as a chiral synthon for 
construction of the dehydroproline core (Scheme 2). 
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Scheme 2. Synthesis of the salicyldehydroproline core. Reagents and conditions: (a) i. 2-[(2-
methoxyethoxy)methoxy]benzoic acid, 1-chloro-N,N,2-trimethyl-1-propenylamine, CH2Cl2, 0 °C 
to rt, 1 h; ii. NEt3, toluene, 80 °C, 3 h, 82%; (b) LiBHEt3, toluene, -78 °C, 1 h, then TFAA, 
DIPEA, cat. DMAP, -78 °C to rt, 3 h, 62%; (c) LiOH, EtOH : H2O, 0 °C to rt, 5 h, 97%. 
 
We planned to acylate the lactam with a suitably protected salicylic acid before the reduction. 
The choice of the phenolic protecting group proved to be nontrivial, as it affected the outcome of 
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the reductive elimination step. In fact, every attempt to use O-acetyl salicyloyl chloride 
(commercially available) led to the dehydroproline moiety in very poor yield, together with 
compounds deriving from hydrolysis of the acetate group. Replacement of acetate with allyl, 
benzyl, or 4-methoxybenzyl ethers led to the decomposition of the starting material. The use of 
2-methoxyethoxymethyl (MEM) ether seemed to be more promising, as the MEM protected 
salicyl-5-oxopyrrolidine underwent smooth reduction to the lactamol, followed by base mediated 
in situ elimination to the dehydroproline, in good yield.  
Having found a suitable protecting group, we proceeded with the synthesis of fragment 5, 
(Scheme 2). Ethyl (S)-pyroglutamate 2 was acylated with 2-((2-methoxyethoxy) 
methoxy)benzoic acid5 using Ghosez’s reagent (1-chloro-N,N,2-trimethyl-1-propenylamine) and 
TEA in toluene6 to obtain 3 in 82% yield. Lactam reduction of 3 using LiBHEt3 at -78 °C, 
followed by treatment with TFAA and DIPEA4 afforded compound 4 in 62% yield. Finally, basic 
hydrolysis of the ester gave key intermediate 5. 
With the salicyldehydroproline fragment in hand, attention was focused on the myristamide 
framework (B). We conceived that both hydroxy groups at C2 and C8 could be introduced in a 
stereoselective way using successive the proline-catalysed MacMillan asymmetric α-
hydroxylations of carbonyl compounds7 as key reactions. As the absolute configuration at C2 and 
C8 was unknown, this method could have the further advantage of providing access to all  
stereoisomers, by using the appropriate proline as a catalyst.  
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Scheme 3. Synthesis of dihydroxymyristamide fragment (B). Reagents and conditions: (a) i. L-
proline, PhNO, CHCl3, +4 °C, 2 h, then NaBH4, EtOH, 0 °C, 0.5 h; ii. Zn dust, EtOH /AcOH, rt, 
1 h, 91% over two steps; (b) PMB dimethylacetal, PPTS, CH2Cl2, 0 °C to rt, 2 h; (c) DIBAL, 
CH2Cl2, -78 °C, 2 h, 72% over two steps; (d) (COCl)2, DMSO, NEt3, CH2Cl2, -78 °C, 94%, 2 h; 
(e) n-BuLi, TBSO(CH2)6P+Ph3Br-, THF, -78 °C to rt, 2 h, 74%; (f) TBAF, THF, 0 °C to rt, 1 h, 
88%; (g) (COCl)2, DMSO, NEt3, CH2Cl2, -78 °C, 1 h, 91%; (h) i. L-proline, PhNO, CHCl3, + 4 
°C, 2 h, then NaBH4, EtOH, 0 °C, 0.5 h; ii. Zn dust, EtOH /AcOH, rt, 1 h, 77% over two steps; 
(i) TBS-Cl, imidazole, CH2Cl2, rt, 6 h, 98%; (j) TBDPS-Cl, imidazole, DMF, rt, 16 h, 98%; (k) 
AcOH /THF /H2O, rt, 36 h, 92%; (l) TEMPO, bis(acetoxy)iodobenzene, NaHCO3, MeCN : H2O, 
0 °C, 4 h, 70%; (m) HBTU, HOBT, NH4Cl, DIPEA, DMF, 0 °C to rt, 1 h, 73%; (n) H2, Pd/C, 
MeOH, rt, 12 h, 73%; (o) 5, EDC, CH2Cl2, rt, 16 h, 50%; (p) i. TiCl4, -20 °C, 15 min, ii. TBAF, 
THF, 0 °C to rt, 2 h, 70% over two steps. 
 
Thus, commercially available octanal 6 was subjected to α-hydroxylation using L-proline and 
nitrosobenzene in CHCl3 at +4 °C, followed by in situ reduction with NaBH4 and treatment with 
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zinc to obtain diol 7. The absolute configuration at C2 was assumed to be (R), following that in 
all the examples reported in literature8 the aminoxylation reaction took place in the same 
stereochemical fashion. The optical rotation ([α]D23 = +14.1 (c 1.00, MeOH); lit.9 for (S)-1,2 
octanediol ([α]D23 = -13.6 (c 1.00, MeOH, e.e. 97%), confirmed that we had obtained the (R) 
enantiomer with more than 97% e.e. 
Reaction with 4-methoxybenzaldehyde dimethylacetal in the presence of a catalytic amount of 
pyridinium p-toluenesulfonate (PPTS) gave compound 8, whose reductive cleavage with DIBAL 
provided protected alcohol 9.10 
Swern oxidation11 of the primary alcohol gave aldehyde 10 in 94% yield. Elongation of the chain 
was readily effected by Wittig olefination with tert-butyldimethylsilyloxybutyl (triphenyl) 
phosphonium bromide.12 Selective deprotection of the O-TBS group by TBAF at 0 °C13 
furnished the free primary alcohol 12. The stereoselectivity of the reactions was assessed by 
catalytic hydrogenation of 12, to obtain (R)-tetradecane-1,8-diol, whose optical purity and 
absolute configuration were confirmed by optical rotation measurement ([α]D23 = -0.63 (c 1.1, 
CHCl3; lit.14 for (R) enantiomer [α]D23 = -0.48 (c 1.1, CHCl3, obtained by opening of an epoxide 
with 91% e.e.15); lit.16 [α]D23 = -0.6 (c 1.8, CHCl3). Again, Swern oxidation followed by another 
α -oxyamination reaction allowed the stereoselective introduction of the hydroxy group at C2 in 
compound 14. The (R) configuration at this carbon could be safely assumed on the basis of the 
mechanism of the reaction.7 
The direct oxidation of 1,2 diol 14 to the corresponding α-hydroxycarboxylic acid gave complex 
mixtures.17 After various unsuccessful attempts, the sequential protection of primary and 
secondary alcohol with TBS and TBDPS respectively, followed by selective deprotection and 
oxidation of the hydroxy group at C1, proved to be the optimal choice. This route allowed us to 
introduce at C2 a group resistant to the conditions for the deprotection of the OH at C8. Thus, 
sequential treatment of compound 14 with TBSCl and TBDPSCl, followed by AcOH in 
THF/H2O18 provided compound 17. TEMPO oxidation,19 and coupling with NH4Cl in DMF20 
furnished amide 19. One-pot hydrogenation of the alkene and cleavage of the PMB group21 gave 
the target key fragment 20 in 73% yield. EDC-mediated esterification of the aliphatic chain 20 
with the dehydroproline fragment 5 afforded compound 21. 
Due to the instability of dehydroproline core in acidic medium, the protecting groups were 
sequentially removed under mild, aprotic conditions. After several attempts, we found that 
careful treatment with TiCl4 at -20 °C,22 followed by TBAF mediated desilylation, gave 
promysalin (-)-1 with absolute configuration 2R, 8R, 16S.  
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When this work was in its final stage, Wuest and coworkers3 published an elegant total synthesis 
of all promysalin stereoisomers and assigned the absolute configuration (2R, 8R, 16S) to the 
natural compound. 
Wuest’s synthesis of the aliphatic chain appears more efficient than ours, giving the 2,8-
dihydroxymyristamide moiety in 45% overall yield from 5-hexenoic acid over 6 steps. On the 
contrary, their approach to the synthesis of the salicyldehydroproline fragment appears less 
straightforward, requiring 7 steps from methyl salicylate to obtain the SEM-protected acid for 
coupling with the alcohol moiety.  
The combination of the two routes would most likely offer the best pathway to a convergent 
synthesis of the natural compound and could be easily transposed to a large scale. The combined 
strategy could also be optimal for the preparation of promysalin analogues for SAR studies and 
further exploration of the intriguing modes of action of this compound.3 
 
3. Conclusions 
In summary, a total synthesis of the antibiotic Promysalin was designed and carried out. Crucial 
steps for our strategy included a MacMillan asymmetric α-hydroxylation of carbonyl compounds 
applied for the construction of the myristamide framework, and a lactam reduction by 
Superhydride ® to obtain the salicyldehydroproline fragment. Because of the modular nature of 
the synthesis, work is in progress to prepare analogues for biological evaluation. 
 
 
4. Experimental section  
4.1. General Information 
All reagents and solvents were reagent grade or were purified by standard methods before use. 
Melting points were determined in open capillaries by a SMP3 apparatus and are uncorrected. 1H 
spectra were recorded on Bruker AMX 300 MHz and Bruker AV600 spectrometers. TMS was 
used as an internal standard and the chemical shifts were reported in parts per million (δ). The 
peak patterns are indicated as follows: s, singlet; d, doublet; dd, doublet of doublet; t, triplet; m, 
multiplet; q, quartet. The coupling constants, J are reported in Hertz (Hz). and 13C NMR spectra 
were recorded on Bruker AMX 300 MHz and Bruker AV600 spectrometers. Optical rotations 
were measured with a Perkin Elmer 241 polarimeter.. IR spectra were recorded on a Perkin 
Elmer 1310 spectrophotometer and reported in wave numbers (cm-1).. The elemental analyses 
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were recorded with a CARLO ERBA EA 1108 instrument. Solvents were routinely distilled prior 
to use; anhydrous tetrahydrofuran (THF) and ether (Et2O) were obtained by distillation from 
sodium-benzophenone ketyl; dry methylene chloride was obtained by distillation from 
phosphorus pentoxide. All reactions requiring anhydrous conditions were performed under a 
positive nitrogen flow and all glassware were oven dried and/or flame dried. Isolation and 
purification of the compounds were performed by flash column chromatography on silica gel 60 
(230-400 mesh). Analytical thin-layer chromatography (TLC) was conducted on TLC plates 
(silica gel 60 F254, aluminum foil). Compounds on TLC plates were detected under UV light at 
254 and 365 nm or were revealed spraying with 10% phosphomolybdenic acid (PMA) in ethanol. 
 
4.2. Experimental procedures and spectroscopic data 
 
4.2.1. Ethyl (S)-1-(2-((2-methoxyethoxy)methoxy)benzoyl)-5-oxopyrrolidine-2-carboxylate (3). 
Ghosez’s reagent (1-chloro-N,N,2-trimethyl-1-propenylamine) (2.5 mL, 0.02 mol) was added 
dropwise to a solution of 2-((2-methoxyethoxy)methoxy)benzoic acid5 (4.1 g, 0.02 mol) in dry 
dichloromethane (40 mL) at 0 °C under N2 atmosphere. The reaction mixture was stirred at room 
temperature for 1 h. The solvent was removed in vacuo and the residue was dried under vacuum 
and used in the next step without purification. In another 2-necked dry flask was placed ethyl L-
pyroglutamate (1.4 g, 9.2 mmol) in dry toluene (15 mL) and the solution was cooled to 0 °C. To 
this was added NEt3 (3.2 mL, 0.02 mol) followed by dropwise addition of the crude acid chloride 
solution in toluene (15 mL). The reaction mixture was heated at 80 °C for 3 h, and then it was 
cooled to room temperature and quenched by addition of saturated aqueous NaHCO3 (30 mL). 
The organic layer was separated and the aqueous layer was extracted with ethyl acetate (2 × 100 
mL). The combined organic extracts were washed with brine (30 mL), dried over anhydrous 
Na2SO4 and concentrated in vacuo. Purification of the residue by flash column chromatography 
in 0-18% acetone : hexane gave 3 (2.75 g, 82%) as a yellow gummy solid; Rf  (20% acetone : 
hexane, double run) = 0.30. [α]D23 = +30.9 (c 1.0, CHCl3); νmax (thin film) : 3045, 1760, 1700, 
1620, 1510, 1470, 1340, 1280, 1250, 1210, 1120, 1010, 750, 710 cm-1.  1H NMR (300 MHz, 
CDCl3) δ = 7.40 (dd, J = 7.5, 7.5 Hz, 1H), 7.31 (d, J = 7.5 Hz, 1H), 7.21 (d, J = 7.5 Hz, 1H), 7.05 
(dd, J = 7.5, 7.5 Hz, 1H), 5.27 (d, J = 7.0 Hz, AB, 1H), 5.23 (d, J = 7.0 Hz, AB, 1H), 4.91 (dd, J 
= 2.9, 9.5 Hz, 1H), 4.28 (q, J = 7.3 Hz, 2H), 3.80 (t, J = 4.5 Hz, 2H), 3.55 (t, J = 4.5 Hz, 2H), 
3.38 (s, 3H), 2.73-2.64 (m, 1H), 2.55-2.50 (m, 1H), 2.50-2.45 (m, 1H), 2.2-2.10 (m, 1H), 1.33 (t, 
J = 7.3 Hz, 3H) ppm. 13C NMR (150 MHz, CDCl3) δ = 172.8, 170.9, 167.8, 154.5, 131.8, 128.4, 
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125.8, 121.6, 114.5, 93.9, 71.6, 67.7, 61.7, 58.9, 58.2, 31.6, 21.7, 14.1 ppm. Elemental analysis 
calcd (%) for C18H23NO7: C 59.17, H 6.34, N 3.83; Found: C 59.38, H 6.32, N 3.84. 
 
4.2.2. Ethyl (S)-1-(2-((2-methoxyethoxy)methoxy)benzoyl)-2,3-dihydro-1H-pyrrole-2-carboxylate 
(4). 
To a stirred solution of 3 (1.1 g, 3.0 mmol) in dry toluene (22 mL) was added Superhydride ® 
(3.6 mL, 3.6 mmol, 1 M in THF) at -78 °C under N2 atmosphere. The solution was stirred for 1 h 
at -78 °C, then DMAP (7 mg, 0.06 mmol) and DIPEA (2.8 mL, 0.02mol) were added, followed 
by very slow addition of TFAA (0.5 mL, 3.6 mmol) over 5 min. The reaction mixture was 
gradually warmed to room temperature and stirred for 3 h. Water (30 mL) was added and the 
organic layer was separated. The aqueous layer was extracted with ethyl acetate (2 × 75 mL); the 
combined organic extracts were washed with brine (15 mL), dried over anhydrous Na2SO4 and 
concentrated in vacuo. The residue was purified using flash column chromatography in 0-50 % 
ethyl acetate: hexane to give 4 (650 mg, 62%) as a yellow oil; Rf  (35% ethyl acetate: hexane) = 
0.30. [α]D23 = -104.3 (c 1.00, CHCl3); νmax (liquid film) : 3050-2800 (br), 1760, 1660, 1640, 
1620, 1510, 1470, 1425, 1250, 1210, 1110, 1045, 1000, 860, 780 cm-1. 1H NMR (300 MHz, 
CDCl3): δ = 7.41-7.34 (m, 2H,), 7.23 (d, J = 7.8 Hz, 1H), 7.07 (dd, J = 7.8, 7.8 Hz, 1H), 6.2 (m, 
1H), 5.30 (s, 2H), 5.10-5.03  (m, 1H), 5.00 (dd, J = 3.6, 10.5 Hz, 1H), 4.27 (q, J = 7.2 Hz, 2H), 
3.86-3.81 (m, 2H,), 3.57-3.52 (m, 2H), 3.37 (s, 3H), 3.18-3.13 (m, 1H,), 2.74-2.69 (m, 1H), 1.33 
(t, J = 7.2 Hz, 3H) ppm. 13C NMR (150 MHz, CDCl3) δ = 170.8, 164.9, 153.4, 131.2, 130.8, 
128.8, 125.9, 122.1, 115.3, 108.5, 93.7, 71.5, 67.9, 61.3, 59.0, 58.0, 34.1, 14.1 ppm. Elemental 
analysis calcd (%) for C18H23NO6: C 61.88, H 6.64, N 4.01; found: C 62.01, H 6.62, N 4.00. 
 
4.2.3. (S)-1-(2-((2-methoxyethoxy)methoxy)benzoyl)-2,3-dihydro-1H-pyrrole-2-carboxylicacid 
(5).  
A solution of 4 (920 mg, 2.6 mmol) in EtOH (22.5 mL) was cooled to 0 °C. To this was added 
dropwise a solution of LiOH (166 mg, 3.9 mmol) in water (11.25 mL). After complete addition 
the reaction mixture was warmed to room temperature and stirred for 5 h. EtOH was removed in 
vacuo, the aqueous layer was washed with 40 % ethyl acetate in diethyl ether (2 × 25 mL), 
cooled to 0 °C and acidified using 5% citric acid. The product was extracted using 5% methanol : 
dichloromethane (3 × 100 mL). The combined organic extracts were washed with brine (15 mL), 
dried over anhydrous Na2SO4 and concentrated to afford pyrroline-carboxylic acid 5 (809 mg, 
97%) as a pale yellow gummy solid; Rf  (5% methanol : dichloromethane) = 0.35. [α]D23 = -97.6 
(c 1.00, CHCl3); νmax (thin film) 3300-2900 (br), 1760, 1660, 1640, 1625, 1505, 1475, 1440, 
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1292, 1005, 760, 725 cm-1. 1H NMR (600 MHz, CDCl3) δ  = 7.38 (dd, J = 7.9, 7.9 Hz, 1H), 7.35 
(d, J = 7.9 Hz, 1H), 7.20 (d, J = 7.9 Hz, 1H), 7.05 (dd, J = 7.9, 7.9 Hz, 1H), 6.62 (brs, 1H), 6.09 
(d, J = 2.2 Hz, 1H), 5.28-5.25 (m, 2H), 5.17-5.22 (m, 1H), 5.08 (dd, J = 4.9, 10.1 Hz, 1H), 3.80-
3.76 (m, 2H), 3.52 (t, J = 4.7 Hz, 2H), 3.34 (s, 3H), 3.08-3.02 (m, 2H) ppm. 13C NMR (150 MHz, 
CDCl3) δ  = 172.2, 167.1, 153.4, 131.8, 129.7, 128.8, 124.8, 122.1, 115.1, 111.2, 93.7, 71.5, 68.0, 
58.9, 53.4, 32.9 ppm. Elemental analysis calcd (%) for C16H19NO6: C 59.81, H 5.96, N 4.36, 
found: C 59.99, H 5.94, N 4.35.  
4.2.4. (R)-octane-1,2-diol (7). 
A suspension of L-proline (322 mg, 2.8 mmol) in CHCl3 (30 ml) was cooled to 4 °C and stirred 
for 15 min, then nitrosobenzene (3 g, 0.03 mol) was added in one portion. At this time the 
solution turned green. To this suspension was added octanal (13.1 ml, 84.0 mmol) in one portion. 
The resulting solution was then stirred at 4 °C for 2 h and it turned yellow. The reaction mixture 
was then added dropwise to an ethanol (25 mL) suspension of NaBH4 (1.05 g, .0.03 mol) at 0 °C. 
After 30 min, the reaction was treated with saturated aqueous NaHCO3 (50 mL). The aqueous 
layer was extracted with dichloromethane (3 ×75 mL); the combined organic extracts were 
washed with brine, dried over anhydrous Na2SO4, filtered and concentrated in vacuo. To a 
solution of the oxy-aniline adduct (14.6 g) in EtOH/AcOH (3:1, 156 mL), Zn dust (8.1 g, 0.12 
mol) was added portionwise. The resulting suspension was stirred at room temperature for 1 h. 
The reaction mixture was filtered through a plug of celite and the residue was washed with 
ethanol (50 mL); the filtrate was concentrated in vacuo at a temperature <40 °C. The residue was 
dissolved in ethyl acetate (200 mL) and washed with saturated aqueous NaHCO3 solution (100 
mL), brine (50 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The 
resulting yellow oil was purified using flash column chromatography (eluent: 20-50% ethyl 
acetate : hexane) to afford (R)-octane-1,2-diol 7 (3.7 g, 91%) as an off-white sticky solid; Rf  
(50% ethyl acetate : hexane) = 0.35. [α]D23  = +14.1 (c 1.00, MeOH); νmax (liquid film) 3600-
3300 (br), 3100, 1550, 1490, 1445, 1290, 1130, 950 cm-1. 1H NMR (600 MHz, CDCl3) δ  = 3.76-
3.70 (m, 1H), 3.67 (dd, J = 3.2, 11.1 Hz, 1H), 3.45 (dd, J = 7.9, 11.1 Hz, 1H), 2.50-2.35 (m, 2H), 
1.49-1.26 (m, 10H), 0.90 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (150 MHz, CDCl3): δ  = 72.3, 66.8, 
33.2, 31.7, 29.3, 25.5, 22.6, 14.0 ppm. Elemental analysis calcd (%) for C8H18O2: C 65.71, H 
12.41; found: C 65.50, H 12.44. 
 
4.2.5. (R)-2-(4-methoxybenzyloxy)octan-1-ol (9).  
A solution of (R)-octane-1,2-diol 7 (7.4 g, 0.05 mol), PPTS (254 mg, 1.1 mmol) in dry 
dichloromethane (126 mL) was cooled to 0 °C. 4-Methoxybenzaldehyde dimethylacetal (12.9 
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mL, 0.08 mol) was added dropwise. The reaction mixture was stirred at room temperature for 2 h 
under N2 atmosphere. Excess NEt3 (10 mL) was added, and then the reaction mixture was 
concentrated in vacuo. The product was filtered through a short pad of silica gel (neutralized with 
5 % NEt3 in hexane) in 1% ethyl acetate: hexane to afford (R)-4-hexyl-2-(4-methoxyphenyl)-1,3-
dioxolane 8. (16 g of crude compound, mixture of diastereomers.) as a yellow oil; Rf (5% ethyl 
acetate : hexane) = 0.55. Compound 8 was unstable, thus it was used immediately in the next step 
without further purification. 
To a stirred solution of 8 (16.0 g, crude) in dry dichloromethane (300 mL), DIBAL (90.90 mL, 
0.09 mol, 1 M in dichloromethane) was added dropwise at -78 °C under N2 atmosphere and 
stirred for 2 h at -78 °C. The reaction mixture was gradually warmed to -20 °C over 1 h, 
methanol (5 mL) was added dropwise and the resulting solution was stirred for 5 min. Dilution 
with diethyl ether (150 mL) followed by addition of saturated aqueous solution of Rochelle’s salt 
(150 mL) gave a thick suspension which was stirred vigorously until the two layers become 
clear. The organic layer was separated; and the aqueous layer was extracted with ethyl acetate (3 
× 150 ml). The combined organic extracts were washed with brine (100 mL), dried over 
anhydrous Na2SO4 and concentrated in vacuo. Purification using flash column chromatography 
in 0-12% ethyl acetate: hexane gave 9 (9.7 g, 72% over two steps) as a pale yellow oil. Rf  (15% 
ethyl acetate : hexane) = 0.46. [α]D23 = -17.5 (c 1.00, CHCl3); νmax (liquid film) 3650-3300 (br), 
1640, 1620, 1540, 1495, 1370, 1205, 1100, 850 cm-1. 1H NMR (600 MHz, CDCl3) δ = 7.30 (d, J 
= 8.5 Hz, 2H), 6.91 (d, J = 8.5 Hz, 2H), 4.58 (d, J = 11.4 Hz, AB, 1H), 4.49 (d, J = 11.4 Hz, AB, 
1H), 3.74-3.68 (s, 3H), 3.70 (m, 1H), 3.55-3.48 (m, 2H), 2.00 (brs, 1H), 1.70-1.62 (m, 1H), 1.55-
1.48 (m, 1H), 1.39-1.25 (m, 8H), 0.91 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (150 MHz, CDCl3) 
δ = 159.3, 130.6, 129.4 (× 2), 113.9 (× 2); 79.5, 71.2, 64.3, 55.3, 31.8, 30.8, 29.5, 25.4, 22.6, 14.1 
ppm. Elemental analysis calcd (%) for C16H26O3: C 72.14, H 9.84; found: C 72.39, H 9.81. 
 
4.2.6. (R)-2-(4-methoxybenzyloxy)octanal (10).  
To a stirred solution of oxalyl chloride (8.8 mL, 0.10 mol) in dry dichloromethane (286 mL), was 
added DMSO (9.7 mL, 0.14 mol) in dry dichloromethane (143 mL) dropwise at -78 °C under N2 
atmosphere. Stirring was continued for 15 min, then 9 (9.1 g, 0.03 mol) in dry dichloromethane 
(143 mL) was added dropwise. After complete addition, the reaction mixture was stirred at -78 
°C for 1 h, then NEt3 (47 mL, 0.34 mol) was added dropwise. The reaction mixture was gradually 
warmed to 0 °C and stirred at this temperature until complete conversion was observed. The 
mixture was diluted with diethyl ether (50 mL) and poured in cold sat. NaHCO3 (140 mL). The 
organic layer was separated and the aqueous layer was extracted with diethyl ether (3 × 100 mL). 
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The combined organic extracts were washed with brine (75 mL), dried over anhydrous Na2SO4 
and concentrated in vacuo. Purification using flash column chromatography in 0-5% ethyl 
acetate: hexane gave aldehyde 10 (8.5 g, 94%) as a colorless oil. Rf  (4% ethyl acetate : hexane) = 
0.47. [α]D23 = +37.8 (c 0.75, MeOH); 1H NMR (600 MHz, CDCl3)  δ = 9.63 (d, J = 2.3 Hz, 1H), 
7.30 (d, J = 8.5 Hz, 2H), 6.91 (d, J = 8.5 Hz, 2H), 4.62 (d, J = 11.8 Hz, AB, 1H), 4.50 (d, J = 
11.4 Hz, AB, 1H), 3.82 (s, 3H), 3.78-3.72 (m, 1H), 1.71-1.63 (m, 2H), 1.49-1.20 (m, 8H), 0.91 (t, 
J = 7.1 Hz, 3H) ppm. 13C NMR (150 MHz, CDCl3) δ = 204.1, 159.5, 129.7 (×2), 129.4, 113.9 
(×2), 83.2, 72.2, 55.2, 31.6, 30.0, 29.0, 24.7, 22.5, 14.0 ppm. Elemental analysis calcd (%) for 
C16H24O3: C 72.69, H 9.15; found: C 72.92, H 9.12. 
 
4.2.7. (R)-Z-8-(4-methoxybenzyloxy)tetradec-6-enyloxy)tert-butyldimethylsilane (11). 
To a stirred suspension of TBSO(CH2)6P+Ph3Br-12 (11.85 g, 0.021 mol) in anhydrous THF (76 
mL) cooled to -78 °C, n-BuLi (12.35 mL, 0.02 mol, 1.6 M in hexane) was added. The brown red 
coloured suspension obtained was stirred at -78 °C for 30 min under N2 atmosphere. Compound 
10 (4.0 g, 0.01mol) in anhydrous THF (76 mL) was added dropwise; on complete addition the 
solution turned pale yellow. The reaction mixture was stirred at -78 °C for 15 min, warmed to 
room temperature and stirred for 2 h. After addition of saturated NH4Cl (100 mL), the product 
was extracted with diethyl ether (3 × 100 mL). The combined organic extracts were washed with 
brine (30 mL), dried over anhydrous Na2SO4 and concentrated in vacuo. Purification by flash 
column chromatography in 0-1% ethyl acetate: hexane yielded 11 (5.2 g, 74%) as a colorless oil; 
Rf  (1% ethyl acetate : hexane) = 0.36. [α]D23 = +15.6 (c 1.00, CHCl3). νmax (liquid film) 3050, 
1570, 1550, 1535, 1480, 1290, 1110, 860, 760, 730 cm-1. 1H NMR (600 MHz, CDCl3)  δ = 7.24 
(d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.5 Hz, 2H), 5.59 (dt, J = 11.0, 7.3 Hz, 1H), 5.29 (dd, J = 11.0, 
9.4 Hz, 1H), 4.49 (d, J = 11.6 Hz, AB, 1H), 4.24 (d, J = 11.6 Hz, AB, 1H), 4.12-4.02 (m, 1H), 
3.80 (s, 3H), 3.60 (t, J = 6.4 Hz, 2H), 2.12-1.95 (m, 2H), 1.73-1.18 (m, 16H), 0.89 (m, 12 H), 
0.05 (s, 6H) ppm. 13C NMR (75 MHz, CDCl3, 23 °C) δ = 158.9, 133.1, 131.2 (×2), 129.2 (×2), 
113.6 (×2), 73.8, 69.4, 63.1, 55.2, 35.8, 32.7, 31.8, 29.6, 29.3, 27.8, 26.0 (×3), 25.5, 25.4, 22.6, 
18.3, 14.1, -5.3 (×2) ppm. Elemental analysis calcd (%) for C28H50O3Si: C 72.67, H 10.89; found: 
C 72.40, H 10.92. 
 
4.2.8. (R)-8-(4-methoxybenzyloxy)tetradec-6-en-1-ol (12).  
A solution of TBS ether 11 (9.5 g, 0.02 mol) in anhydrous THF (82 mL) was cooled to 0 °C. 
TBAF (61 mL, 0.06 mol, 1 M in THF) was added at 0 °C under N2 atmosphere. The reaction 
mixture was warmed to room temperature and stirred for 1 h. Saturated NH4Cl (125 mL) was 
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added, and the organic layer was separated. The aqueous layer was extracted with ethyl acetate (3 
× 150 mL), and the combined organic extracts were washed with brine (80 mL), dried over 
anhydrous Na2SO4 and concentrated in vacuo. The residue was purified using flash column 
chromatography in 0-15% ethyl acetate: hexane to afford desired 12 (6.3 g, 88%) as a pale 
yellow oil; Rf  (15% ethyl acetate: hexane) = 0.41. [α]D23 = +20.0 (c 1.00, CHCl3). νmax (liquid 
film) 3600-3200 (br), 3090, 3020, 1640, 1530, 1480, 1320, 1290, 1280, 1105, 1050, 760 cm-1.   
1H NMR (300 MHz, CDCl3) δ  7.26 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 5.61 (dt, J = 
11.0, 7.3 Hz, 1H), 5.31 (dd, J = 11.0, 9.5 Hz, 1H), 4.51 (d, J = 11.9 Hz, AB, 1H), 4.27 (d, J = 
11.9 Hz, AB, 1H), 4.15-4.05 (m, 1H), 3.82 (s, 3H), 3.65 (t, J = 6.4 Hz, 2H), 2.15-2.00 (m, 2H), 
1.75-1.50 (m, 4H), 1.48-1.30 (m, 12H), 0.88 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, 
CDCl3) δ  = 158.9, 133.0, 131.2, 131.1, 129.2 (×2), 113.7 (×2), 73.8, 69.3, 62.8, 55.3, 35.7, 32.6, 
31.8, 29.5, 29.3, 27.8, 25.4, 25.4, 22.6, 14.1 ppm. Elemental analysis calcd (%) for C22H36O3: C 
75.82, H 10.41; found: C 75.60, H 10.43. 
 
4.2.9. (R)-8-(4-methoxybenzyloxy)tetradec-6-enal (13). 
To a stirred solution of oxalyl chloride (4.7 mL, 0.05 mol) in dry dichloromethane (150 mL), a 
solution of DMSO (5.1 mL, 0.07 mol) in dry dichloromethane (75 mL) was added dropwise at -
78 °C under N2 atmosphere and stirred for 15 min. Tetradecanol 12 (6.3 g, 0.02 mol) in dry 
dichloromethane (75 mL) was added dropwise. After complete addition, the reaction mixture was 
stirred at -78 °C for 1 h. After addition of NEt3 (25 mL, 0.18 mol), the reaction mixture was 
gradually warmed to 0 °C and stirred at this temperature until complete conversion was observed. 
The mixture was diluted with diethyl ether (50 mL) and poured in cold sat. NaHCO3 (80 mL), the 
organic layer was separated and aqueous layer was extracted with diethyl ether (3 × 150 mL). 
The combined organic extracts were washed with brine (50 mL), dried over anhydrous Na2SO4 
and concentrated in vacuo. Purification using flash column chromatography with 0-5% ethyl 
acetate : hexane gave 13 (5.7 g, 91%) as a colorless oil; Rf  (3% ethyl acetate : hexane) = 0.44. 
[α]D23 = +17.8 (c 1.00, CH3OH). 1H NMR (300 MHz, CDCl3) δ  = 9.78 (s, 1H), 7.25 (d, J = 8.8 
Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 5.59 (dt, J = 11.0, 7.3 Hz, 1H), 5.34 (dd, J = 11.0, 9.5 Hz, 1H), 
4.51 (d, J = 11.3 Hz, AB, 1H), 4.26 (d, J = 11.3 Hz, AB, 1H), 4.012-4.02 (m, 1H), 3.82 (s, 3H), 
2.44 (t, J = 7.3 Hz, 2H), 2.12-1.98 (m, 2H), 1.73-1.56 (m, 4H), 1.49-1.35 (m, 4H), 1.32-1.18 (m, 
6H), 0.89 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, MeOD) δ = 200.3, 159.4, 133.2, 130.7, 
129.3, 129.1, 113.5, 113.3, 104.6, 73.4, 69.2, 54.4, 35.5, 32.3, 31.8, 29.4, 29.1, 27.6, 25.2, 24.1, 
22.5, 13.2 ppm. Elemental analysis calcd (%) for C22H34O3: C 76.26, H 9.89; found: C 75.98, H 
9.87. 
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4.2.10. (2R,8R)-8-(4-methoxybenzyloxy)tetradec-6-ene-1,2-diol (14).  
A suspension of L-proline (57.6 mg, 0.5 mmol) in CHCl3 (16.5 mL) was cooled to 4 °C and 
stirred for 15 min, then nitrosobenzene (525 mg, 5 mmol) was added in one portion. At this time 
the solution turned green. To this suspension was added a solution of tetradecanal 13 (3.4 g, 9.9 
mmol) in CHCl3 (16.5 mL) in one portion. The resulting solution was then stirred at 4 °C for 2 h. 
At this time the solution turned yellow. The reaction mixture was then added to an ethanol (50 
mL) suspension of NaBH4 (374 mg, 9.9 mmol) at 0 °C. After 30 min. the reaction was treated 
with saturated aqueous NaHCO3 (125 mL). The aqueous layer was extracted with 
dichloromethane (3 × 150 mL). The combined organic extracts were washed with brine (50 mL), 
dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The oxy-aniline adduct (4.1 g) 
was dissolved in EtOH/AcOH (3:1, 30 mL) and Zn dust (1.2 g, 0.02 mol) was added portionwise. 
The resulting suspension was stirred at room temperature for 1 h. The reaction mixture was 
filtered through a plug of celite and the residue was washed with ethanol (25 mL). The filtrate 
was concentrated in vacuo at <40 °C. The residue was dissolved in ethyl acetate (200 mL) and 
washed with a saturated NaHCO3 solution (100 mL), brine (50 mL), dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo. The resulting yellow oil was purified using flash 
column chromatography with 20% - 50% ethyl acetate : hexane to afford 1,2 diol 14 (2.78 g 
77%) as a yellow oil; Rf  (40% ethyl acetate : hexane) = 0.36. [α]D23 = +18.9 (c 1.00, CHCl3); νmax 
(liquid film) 3600-3200 (br), 3090, 1640, 1540, 1482, 1090, 1070, 760, 730 cm-1.  1H NMR (300 
MHz, CDCl3) δ = 7.23 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.5 Hz, 2H), 5.56 (dt, J = 11.0, 7.3 Hz, 
1H), 5.32 (dd, J = 11.0, 9.5 Hz, 1H), 4.49 (d, J = 11.4 Hz, AB, 1H), 4.25 (d, J = 11.4 Hz, AB, 
1H), 4.12-4.02 (m, 1H); 3.79 (s, 3H), 3.71-3.53 (m, 2H), 3.45-3.35 (m, 1H), 2.88 (brs, 1H), 2.26 
(brs, 1H), 2.15-1.95 (m, 2H), 1.73-1.15 (m, 14H), 0.87 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (75 
MHz, CDCl3) δ = 159.1, 132.8, 131.6, 131.1, 129.4 (×2), 113.8 (×2), 73.9, 72.2, 69.5, 66.8, 55.4, 
35.8, 32.8, 31.9, 29.4, 27.8, 25.8, 25.5, 22.7, 14.2 ppm. Elemental analysis calcd (%) for 
C22H36O4: C 72.49, H 9.95, found: C 72.70, H 9.94. 
 
4.2.11.(2R,8R)-Z-1-((tert-butyldimethylsilyl)oxy)-8-(4-methoxybenzyloxy)tetradec-6-en-2-ol (15). 
To a stirred solution of tetradecane 1,2 diol 14 (400 mg, 1.1 mmol) in dry dichloromethane (11 
mL) was added imidazole (149 mg, 2.2 mmol), then TBSCl (215 mg, 1.4 mmol) was added 
portionwise at 0 °C. The reaction mixture was warmed to room temperature and stirred for 6 h, 
then it was quenched by addition of ice; the aqueous layer was extracted with dichloromethane (2 
× 30 mL). The combined organic extracts were washed with brine (20 mL), dried over anhydrous 
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Na2SO4 and concentrated in vacuo. The residue was purified using flash column chromatography 
(0 - 8% ethyl acetate : petroleum ether) to afford mono TBS ether 15 (518 mg, 98%) as a 
colorless oil; Rf (5% ethyl acetate : hexane) = 0.35. [α]D23 = +14.3 (c 1.00, CHCl3); νmax (liquid 
film) 3610, 3580-3400 (br), 1625, 1605, 1530, 1480, 1260, 1120, 1090, 1050, 850, 795 cm-1.  1H 
NMR (300 MHz, CDCl3) δ 7.26 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 5.61 (dt, J = 11.0, 
7.3 Hz, 1H), 5.33 (dd, J = 11.0, 9.5 Hz, 1H), 4.51 (d, J = 11.3 Hz, AB, 1H), 4.26 (d, J = 11.3 Hz, 
AB, 1H), 4.12-4.02 (m, 1H), 3.82 (s, 3H), 3.69-3.59 (m, 2H), 3.40 (dd, J = 8.5, 10.4 Hz, 1H), 
2.17-1.96 (m, 2H), 1.74-1.11 (m, 14H), 0.92 (s, 9H), 0.89 (t, J = 7.0 Hz, 3H), 0.09 (s, 6H) ppm. 
13C NMR (75 MHz, CDCl3) δ  159.1, 132.9, 131.6, 131.2, 129.3 (×2), 113.8 (×2), 73.9, 71.7, 
69.5, 67.3, 55.4, 35.9, 32.5, 32.0, 29.4, 27.9, 26.0 (×3), 25.9, 25.5, 22.7, 18.4, 14.2, -5.2, -5.3 
ppm. Elemental analysis calcd (%) for C28H50O4Si: C 70.24, H 10.53; found: C 70.01, H 10.54. 
 
4.2.12.(R)-5-((R)-Z-6-((4-methoxybenzyl)oxy)dodec-4-en-1-yl)-2,2,8,8,9,9-hexamethyl-3,3-
diphenyl-4,7-dioxa-3,8-disiladecane (16). 
A solution of mono TBS ether 15 (518 mg, 1.1 mmol), imidazole (220 mg, 3.2 mmol) in dry 
DMF (5.4 mL) was cooled to 0 °C. TBDPS-Cl (0.42 mL, 1.6 mmol) was added dropwise at 0 °C. 
After complete addition, the reaction mixture was stirred at room temperature under N2 
atmosphere for 12 h. TLC showed partial completion of reaction, thus another (302 mg, 1.1 
mmol of TBDPS-Cl was added and stirred for further 8 h. The reaction was quenched by addition 
of ice; the aqueous layer was extracted with diethyl ether (3 × 50 mL), then the combined organic 
extracts were washed with brine (30 mL), dried over anhydrous Na2SO4 and concentrated in 
vacuo. The residue was purified using flash column chromatography with 0-3% ethyl acetate: 
petroleum ether) to afford bis-silyl ether 16 (773 mg, 98%) as a yellow oil; Rf  (2% ethyl acetate : 
hexane) = 0.47. [α]D23 = +5.5 (c 1.2, CHCl3). νmax (liquid film) 3100, 1630, 1520, 1480, 1265, 
1120, 850, 720 cm-1.  1H NMR (300 MHz, CDCl3) δ = 7.76-7.65 (m, 4H), 7.47-7.31 (m, 6H), 
7.24 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 5.51 (dt, J = 11.0, 7.0 Hz, 1H), 5.27 (dd, J = 
11.0, 9.5 Hz, 1H), 4.48 (d, J = 11.6 Hz, AB, 1H), 4.21 (d, J = 11.6 Hz, AB, 1H), 4.011-4.01 (m, 
1H), 3.81 (s, 3H), 3.85-3.71 (m, 1H), 3.53-3.38 (m, 2H), 2.00-1.84 (m, 2H), 1.65-1.20 (m, 14H), 
1.06 (s, 9H), 0.89 (t, J = 7.0 Hz, 3H), 0.83 (s, 9H), 0.06 (s, 3H), 0.01 (s, 3H) ppm. 13C NMR (75 
MHz, CDCl3) δ  = 159.1, 136.0 (×6), 134.6, 134.5, 133.3, 131.3, 129.7, 129.4, 127.6 (×5), 113.7 
(×2), 74.1, 73.6, 69.6, 66.3, 55.4, 35.9, 33.6, 32.0, 29.5, 28.1, 27.2 (×3), 26.0 (×3), 25.5, 24.8, 
22.8, 19.5, 18.4, 14.3, -5.3 (×2) ppm. Elemental analysis calcd (%) for C44H68O4Si2: C 73.69, H 
9.56: found: C 73.50, H 9.55.  
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4.2.13.(2R,8R)-Z-2-((tert-butyldiphenylsilyl)oxy)-8-((4-methoxybenzyl)oxy)tetradec-6-en-1-ol 
(17).  
A mixture of bis-silyl ether 16 (698 mg, 0.9 mmol) in AcOH/ THF/ H2O 3 : 1: 1 (36 mL) was 
stirred at room temperature for 36 h. The reaction was quenched by addition of saturated aq. 
K2CO3 (50 mL), followed by addition of solid K2CO3. The aqueous layer was extracted with 
ethyl acetate (2 × 50 mL). The combined organic extracts were washed with brine (30 mL), dried 
over anhydrous Na2SO4 and concentrated in vacuo. Purification using flash column 
chromatography with 0-8% ethyl acetate: petroleum ether produced 17 (500 mg, 92%) as a 
yellow oil; Rf  (5% ethyl acetate : hexane) = 0.56. [α]D23 = -18.07 (c 1.3, CHCl3); νmax (liquid 
film) 3610, 3580-3300 (br), 1635, 1600, 1530, 1480, 1445, 1270, 1120, 840, 760, 730 cm-1.   1H 
NMR (300 MHz, CDCl3): δ = 7.75-7.58 (m, 4H); 7.49-7.32 (m, 6H); 7.21 (d, J = 8.6 Hz, 2H); 
6.85 (d, J = 8.6 Hz, 2H); 5.41 (dt, J = 11.2, 7.4 Hz, 1H); 5.24 (dd, J = 11.2, 9.6 Hz, 1H); 4.44 (d, 
J = 11.4 Hz, AB, 1H); 4.18 (d, J = 11.4 Hz, AB, 1H); 4.07-3.95 (m, 1H); 3.79 (s, 3H,); 3.80-3.72 
(m, 1H); 3.58-3.41 (m, 2H); 1.91-1.73 (m, 2H); 1.66-1.13 (m, 14H); 1.07 (s, 9H); 0.87 (t, J = 7.0 
Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3) δ = 159.1, 136.0 (×2), 135.8 (×2), 134.0, 133.8, 132.7, 
131.5, 131.2, 129.9 (×2), 129.3 (×2), 127.9 (×4), 113.8 (×2), 1C overlapped to the solvent signal, 
74.0, 69.5, 66.0, 55.4, 35.8, 33.3, 31.9, 29.4, 27.8, 27.2 (×4), 25.5, 22.7, 19.5, 14.2 ppm. 
Elemental analysis calcd (%) for C38H54O4Si: C 75.70, H 9.03; found: C 75.42, H 9.00.  
 
4.2.14. (2R,8R)-Z-2-((tert-butyldiphenylsilyl)oxy)-8-((4-methoxybenzyl)oxy)tetradec-6-enoic acid 
(18). 
A suspension of 17 (340 mg, 0.6 mmol), NaHCO3 (141 mg, 1.7 mmol) in acetonitrile / water (3.4 
mL:3.4 mL) was cooled to 0 °C and stirred for 10 min. TEMPO (17 mg, 0.1 mmol), and 
bis(acetoxy)iodobenzene (451 mg, 1.4 mmol), were added in one portion and the solution was 
stirred at 0 °C for 4 h. Saturated aq. NaHCO3 (20 mL) was added at 0 °C and the aqueous layer 
was extracted with ethyl acetate (2 × 50 mL). The combined organic extracts were washed with 
brine (15 mL), dried over anhydrous Na2SO4 and concentrated in vacuo. The crude oil was 
purified using flash column chromatography (0-20% ethyl acetate: petroleum ether) to furnish 18 
(259 mg, 70%) as a colorless oil; Rf  (20% ethyl acetate : hexane) = 0.43. [α]D23 = +5.9 (c 1.00, 
MeOH). νmax (liquid film) 3100-2800 (br), 1730, 1630, 1605, 1525, 1480, 1445, 1280, 1260, 
1125, 845, 760, 720 cm-1.  1H NMR (300 MHz, CDCl3) δ  7.70-7.53 (m, 4H), 7.51-7.31 (m, 6H), 
7.20 (d, J = 8.2 Hz, 2H), 6.85 (d, J = 8.2 Hz, 2H), 5.48-5.38 (m, 1H), 5.27 (m, 1H), 4.43 (d, J = 
11.4 Hz, AB, 1H), 4.340-4.32 (m, 1H), 4.16 (d, J = 11.4 Hz, AB, 1H), 4.08-3.92 (m, 1H), 3.79 (s, 
3H), 1.95-1.18 (m, 16H), 1.12 (s, 9H), 0.86 (t, J = 6.7 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3) 
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δ = 174.8, 159.1, 135.8 (×4), 135.4, 132.9, 132.4, 131.8, 131.1, 130.5, 130.3, 129.3 (×2), 127.9 
(×4), 113.8 (×2), 73.9, 72.9, 69.5, 55.4, 35.8, 34.3, 31.9, 29.8, 29.4, 27.4, 27.0 (×3), 25.4, 22.7, 
19.4, 14.2 ppm. Elemental analysis calcd (%) for C38H52O5Si: C 73.98, H 8.50; found: C 74.22, 
H 8.52. 
 
4.2.15. (2R,8R)-Z-2-((tert-butyldiphenylsilyl)oxy)-8-((4-methoxybenzyl)oxy)tetradec-6-enamide 
(19).  
A solution of 18 (224 mg, 0.4 mmol), NH4Cl (38 mg, 0.7 mmol) in dry DMF (5 mL) was cooled 
to 0 °C. HOBT (73 mg, 0.5 mmol) and HBTU (205 mg, 0.5 mmol) were added followed by 
DIPEA (0.23 mL, 1.4 mmol). The reaction mixture was warmed to room temperature and stirred 
for 1 h. Ice was added, and then the aqueous layer was extracted with ethyl acetate (2 × 25 mL). 
The combined organic extracts were washed with cold brine (3× 10 mL) and dried over Na2SO4. 
After removal of the solvent in vacuo, the residue was purified using flash column 
chromatography (0-30% ethyl acetate : petroleum ether) to furnish 19 (180 mg, 73%) as a white 
sticky solid; Rf  (25% ethyl acetate : hexane) = 0.45. [α]D23 = -8.9 (c 1.4, CH3OH). νmax (thin film) 
3550, 3505, 3450, 3100, 1700, 1635, 1605, 1580, 1540, 1485, 1450, 1285, 1135, 850, 760 cm-1.  
1H NMR (300 MHz, CDCl3) δ  7.73-7.54 (m, 4H), 7.50-7.30 (m, 6H), 7.20 (d, J = 8.2 Hz, 2H), 
6.85 (d, J = 8.2 Hz, 2H), 6.73 (brs, 1H), 5.78 (brs, 1H), 5.50-5.39 (m, 1H), 5.32-5.22 (m, 1H), 
4.43 (d, J = 11.4 Hz, AB, 1H), 4.33.4.25 (m, 1H), 4.17 (d, J = 11.4 Hz, AB, 1H), 3.98 (m, 1H), 
3.80 (s, 3H), 1.94-1.83 (m, 2H), 1.75-1.15 (m, 14H), 1.12 (s, 9H), 0.87 (t, J = 6.6 Hz, 3H) ppm. 
13C NMR (75 MHz, CDCl3) δ  = 177.7, 160.5, 137.3 (×2), 137.1 (×2), 134.4, 134.0, 133.1, 132.7, 
131.8 (×2), 130.8 (×2), 129.5 (×4), 115.3 (×2), 75.5 (×2), 71.0, 56.8, 37.3, 35.6, 33.4, 31.3, 30.9, 
29.0, 28.6 (×3), 26.9, 25.1, 24.2, 20.8, 15.7 ppm. Elemental analysis calcd (%) for C38H53NO4Si: 
C 74.10, H 8.67, N 2.27; found: C 74.38, H 8.69, N 2.26. 
 
4.2.16. (2R,8R)-2-((tert-butyldiphenylsilyl)oxy)-8-hydroxytetradecanamide (20). 
To a solution of 19 (68 mg, 0.11 mmol) in methanol (6 mL) was added 10% Pd/C (20 mg). The 
suspension was evacuated under vacuum and flushed with H2 gas (4 times). The reaction mixture 
was stirred under H2 atmosphere for 12 h at room temperature, then filtered through a plug of 
celite and the residue was washed with ethyl acetate (10 mL). The filtrate was concentrated in 
vacuo and purified using flash column chromatography (0-40% ethyl acetate: petroleum ether to 
obtain 20 (40 mg, 73%) as a pale yellow oil; Rf  (30% ethyl acetate : hexane) = 0.35. [α]D23 = -
10.1 (c 1.0, CH3OH). νmax (thin film) 3550, 3505, 3450, 3100, 1710, 1604, 1575, 1450, 1299, 
930, 790, 740 cm-1.  1H NMR (300 MHz, CDCl3) δ = 7.70-7.54 (m, 4H), 7.50-7.31 (m, 6H), 6.72 
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(brs, 1H), 5.67 (brs, 1H), 4.27 (t, J = 4.6 Hz, 1H), 3.60-3.50 (m, 1H), 1.94-1.55 (m, 2H), 1.48-
1.15 (m, 19H), 1.12 (s, 9H), 0.89 (t, J = 6.6 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3) δ  = 
176.6, 135.8 (×4), 133.1, 132.6, 130.3 (×2),128.0 (×4), 74.4, 72.0, 37.5, 34.5, 32.0, 29.5, 27.2, 
27.1 (×3), 25.7 (×2), 23.5, 22.8 (×2), 19.4, 14.1 ppm. Elemental analysis calcd (%) for 
C30H47NO3Si: C 72.38, H 9.52, N 2.80; found: C 72.19, H 9.54, N 2.79. 
 
4.2.17. (7R,13R)-14-amino-13-((tert-butyldiphenylsilyl)oxy)-14-oxotetradecan-7-yl (S)-1-(2-((2-
methoxyethoxy)methoxy)benzoyl)-2,3-dihydro-1H-pyrrole-2-carboxylate (21). 
To a stirred solution of pyrrolinecarboxylic acid 5 (66 mg, 0.2 mmol) in dry dichloromethane (8 
mL) was added EDC (52 mg, 0.3 mmol) and  DMAP (5 mg, 0.04 mmol) at 0 °C. A solution of 
20 (69 mg, 0.14 mmol) in dichloromethane (2 mL) was added dropwise at 0 °C. The reaction 
mixture was warmed to room temperature and stirred for 16 h, then it was poured into water (10 
mL) and the organic layer was separated. The aqueous layer was extracted with dichloromethane 
(2 × 25 mL) and the combined organic extracts were washed with brine and dried over anhydrous 
Na2SO4. The solvent was removed in vacuo and the residue was purified using flash column 
chromatography (FCC) with 0-40% ethyl acetate: hexane to furnish 21 (56 mg, 50%) as a pale 
yellow oil; Rf (40% ethyl acetate : hexane) = 0.35. [α]D23 = -44.9 (c 1.0, MeOH); νmax (liquid 
film) 3520, 3410, 3090, 1760, 1710, 1660, 1640, 1440, 1280, 1130, 1010, 920, 790 cm-1.  1H 
NMR (600 MHz, acetone-d6) (mixture of conformers) δ = 7.74-7.65 (m, 4H), 7.53-7.41 (m, 7H), 
7.31 (dd, J = 1.6, 7.6 Hz, 1H), 7.27 (d, J = 8.2 Hz, 1H), 7.14-7.08 (m, 1H), 6.97 (brs, 1H), 6.72 
(brs, 1H), 6.22-6.18 (m, 1H), 5.30 (s, 2H), 5.114-5.10 (m, 1H), 4.95- 4.87 (m, 2H), 4.16 (t, J = 
5.1 Hz, 1H), 3.80 (t, J = 4.8 Hz, 2H), 3.51 (t, J = 4.8 Hz, 2H), 3.27 (s, 3H), 3.20-3.12 (m, 1H), 
2.70-2.55 (m, 1H), 2.20-1.92 (m, 2H), 1.67-1.11 (m, 18H), 1.11 (s, 9H), 0.87 (t, J = 7.3 Hz, 3H) 
ppm. 13C NMR (150 MHz, acetone-d6,) δ  = 175.1, 170.5, 164.1, 153.5, 135.7 (×2), 135.6 (×2), 
133.3, 132.8, 131.0, 130.7, 130.0, 129.5, 128.6, 127.8 (×4), 126.5, 121.8, 115.5, 108.1, 93.7, 
74.5, 74.3, 71.4, 67.9, 58.1, 57.9, 34.5, 34.0, 34.0, 33.8, 31.5, 29.6, 29.5, 26.5 (×3), 25.0, 24.7, 
23.4, 22.3, 18.9, 13.4 ppm. Elemental analysis calcd (%) for C46H64N2O8Si: C 68.97, H 8.05, N 
3.50; found: C 69.20, H 8.03, N 3.52. 
 
4.2.18. (7R,13R)-14-amino-13-hydroxy-14-oxotetradecan-7-yl-(S)-1-(2-hydroxybenzoyl)-2,3-
dihydro-1H-pyrrole-2-carboxylate (1). 
To a stirred solution of 21 (28 mg, 0.03 mmol) in dichloromethane (1 mL) was added TiCl4 (0.13 
mL, 0.13 mmol, 1 M in dichloromethane) at -20 °C. The reaction mixture was stirred at -20 °C 
for 10 min; then aqueous ammonia (2 mL) was added. The aqueous layer was extracted with 
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ethyl acetate (2 × 30 mL), and the combined organic extracts were washed with brine (10 mL) 
and dried over anhydrous Na2SO4. The solvent was removed in vacuo. The crude compound (24 
mg) was dissolved in dry THF (1 mL) and cooled to 0 °C. TBAF (0.1 mL, 0.1 mmol, 1 M in 
THF) was added dropwise. The reaction mixture was warmed to room temperature and stirred for 
1 h, then saturated NH4Cl (5 mL) was added. The aqueous layer was extracted with ethyl acetate 
(2 × 25 mL); and the combined organic extracts were washed with brine (10 mL) and dried over 
anhydrous Na2SO4. After removal of the solvent in vacuo, the residue was purified using 
preparative TLC in 5% methanol : dichloromethane) to furnish 1 (10 mg, 70% over two step) as 
a colorless oil; Rf (3% methanol : dichloromethane) 0.33. [α]D23 = -33.4 (c 1.00, CHCl3). 1H 
NMR (600 MHz, CDCl3) δ = 9.53 (brs, 1H), 7.40-7.34 (m, 2H), 6.97 (d, J = 8.2 Hz, 1H), 6.89 
(dd, J = 7.5, 7.5 Hz, 1H), 6.70 (brs, 1H), 6.59 (brs, 1H), 5.42 (brs, 1H), 5.36-5.26 (m, 1H), 5.00 
(dd, J = 4.7, 11.3 Hz, 1H), 5.02-4.95 (m, 1H), 4.08 (dd, J = 3.6, 8.1 Hz, 1H), 3.60-3.40 (m, 1H), 
3.12 (ddd, J = 17.1, 11.3, 2.5 Hz, 1H), 2.68 (m, 1H), 1.98-1.08 (m, 20H), 0.85 (t, J = 6.8 Hz, 3H) 
ppm. 13C NMR (150 MHz, CDCl3) δ = 177.0, 171.3, 167.4, 158.0, 133.4, 130.8, 128.3, 119.4, 
118.0, 117.8, 111.0, 76.0, 71.4, 59.3, 34.5, 34.3, 34.1, 33.6, 31.8, 29.2, 28.3, 25.5, 24.8, 24.5, 
22.6, 14.1 ppm. Elemental analysis calcd (%) for C26H38N2O6: C 65.80, H 8.07, N 5.90; found: C 
66.02, H 8.05, N 5.91. 
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